Sharekhan

Krishna Institute of Medical Sciences Ltd

Fri 13/02/2026,15:51:10 | NSE : KIMS

₹ 687.20-10.60 (-1.52%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 685.00

Previous Close

₹ 697.80

Volume

585237

Mkt Cap ( Rs. Cr)

₹27497.55

High

₹ 709.55

Low

₹ 670.15

52 Week High

₹ 798.40

52 Week Low

₹ 474.05

Book Value Per Share

₹ 56.74

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Krishna Institute of Medical Sciences Ltd

Your Vote -

Buy

41.57%

Hold

33.71%

Sell

24.72%

41.57%

89 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

687.20

6170

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

6170

Option Chain

Analyzes market sentiment, predicts Krishna Institute of Medical Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Feb 2026, 2:22PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Link of Recording
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    9 Feb 2026, 2:18PM the audio recording of the Company's Conference Call dated February 9, 2026 with Investors/ Analysts for Q3 FY26 is available on the Company's website
  • Krishna Institute - General Update

    7 Feb 2026, 3:21PM General Update
  • Krishna Institute - Updates

    7 Feb 2026, 3:20PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding 'General Update'.
  • Krishna Institute - Copy of Newspaper Publication

    7 Feb 2026, 3:13PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Investor Presentation

    6 Feb 2026, 6:43PM Investor Presentation Q3FY26
  • Krishna Institute - Investor Presentation

    6 Feb 2026, 6:42PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation
  • Krishna Institute Q3 net profit down 5.23% at Rs 72.50 cr

    6 Feb 2026, 6:40PM The company reported standalone net profit of Rs 72.50 crore for the quarter ended December 31, 2025 as compared to Rs 76.50 crore in the same period
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Feb 2026, 6:40PM Press Release Q3FY26
  • Krishna Institute - Press Release

    6 Feb 2026, 6:39PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated February 06, 2026, titled ""Press Release"".
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Acquisition

    6 Feb 2026, 6:36PM Increase in further Limits for acquisition of shares
  • Krishna Institute - Acquisition

    6 Feb 2026, 6:34PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition
  • Krishna Institute - Q3FY26

    6 Feb 2026, 6:31PM Q3FY26
  • Krishna Institute - Outcome of Board Meeting

    6 Feb 2026, 6:24PM Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  • Krishna Institute - Board Meeting Outcome for Outcome Of Board Meeting

    6 Feb 2026, 6:16PM Outcome of Board Meeting Q3FY26
  • Krishna Institute - Outcome of Board Meeting

    6 Feb 2026, 6:12PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Board meeting held on February 06, 2026.
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Feb 2026, 1:32PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Feb 2026, 1:34PM Axis Capital Flagship India Conference
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Feb 2026, 7:12PM Revised Intimation of a conference call for Analysts and Investors.
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Feb 2026, 7:09PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Shareholders meeting

    3 Feb 2026, 5:48PM Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informe
  • Krishna Institute - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    3 Feb 2026, 5:24PM Postal Ballot voting Results
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Feb 2026, 3:03PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Feb 2026, 3:00PM Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Sachin Salvi - Chief Financial O
  • Krishna Institute - Board Meeting Intimation for The Unaudited (Standalone & Consolidated) Financial Results Of The Company F

    2 Feb 2026, 12:37PM Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter
  • Krishna Institute has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    19 Jan 2026, 9:10PM As of December 2025, 34.11% is owned by Indian Promoters and 65.89% by Public. <p align=justify> Institutional holds 47.05% (Insurance Companies 4.76%
  • Krishna Institute - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jan 2026, 1:43PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Krishna Institute - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jan 2026, 1:36PM Certificate U/r 74(5)
  • Krishna Institute - Copy of Newspaper Publication

    3 Jan 2026, 10:56PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Krishna Institute - Shareholders meeting

    2 Jan 2026, 10:40PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
  • Krishna Institute - Receipt Of Demand Order From GST Department By SPANV MEDISEARCH LIFESCIENCES PRIVATE LIMITED (Subsidiary

    1 Jan 2026, 8:31PM Demand Order received by the Subsidiary of the Company.
  • Krishna Institute - Action(s) initiated or orders passed

    1 Jan 2026, 8:28PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Action(s) initiated or orders passed
  • Krishna Institute - Trading Window

    26 Dec 2025, 12:11PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider
  • Krishna Institute - Agreements

    21 Dec 2025, 12:32AM Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into a Leave and License Agreement with Andhra Mahila Sabha for
  • Krishna Institute - Krishna Institute Of Medical Sciences Limited ('The Company') Has Entered Into A Leave And License Agreem

    21 Dec 2025, 12:40AM Company has entered into Leave and License agreement with Andhra Mahila Sabha for taking land on lease loacted at Dr Durgabai Deshmukh Road, Raja Anna
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    19 Dec 2025, 5:56PM Update on the further acquisition of shares of Sarvejana Healthcare Private Limited.
  • Krishna Institute - Acquisition

    19 Dec 2025, 5:54PM Krishna Institute of Medical Sciences Limited has informed the Exchange about the further Acquisition of shares in Sarvejana Healthcare Private Limite
  • Krishna Institute - Commencement Of Operations At PES University Campus In Electronic City, Bengaluru

    15 Dec 2025, 4:32PM Commencement of Operations at PES University in Electronic City, Bengaluru
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Dec 2025, 3:50PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Dec 2025, 3:53PM Meeting with 360One Capital (B&K Securities)
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    14 Nov 2025, 4:04PM JM Financial India Conference
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Nov 2025, 4:01PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Nov 2025, 12:30PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    14 Nov 2025, 12:14PM Transcript of earnings conference call with Investors
  • Krishna Institute of Medical Sciences

    9 Feb 2026 , 10:11AM Krishna Institute of Medical Sciences : The company posted Q3FY26 performance with consolidated revenue growing 29.17% to Rs 9,977 million, though net profit declined 39.80% (impact of capacity expansion). The company approved Rs 100 crore investment in subsidiary Sarvejana Healthcare and completed regulatory compliance filing for newspaper publication of results. (Negative)
  • Krishna Institute enters into an operations & management agreement with Splendid Hospitals

    20 Feb 2025 , 11:40AM Operation & Management Agreement with Splendid Hospitals Pvt. Ltd
  • KIMS Hospitals enters into a strategic partnership with UAIMS Hospital

    18 Feb 2025 , 11:32AM KIMS Hospitals enters into a strategic partnership with Ushahkal Abhinav Institute of Medical Sciences (UAIMS Hospital)
  • Krishna Institute of Medical Science

    18 Feb 2025 , 10:41AM KIMS: Company signs 7-year management agreement with UAIMS Hospital in Sangli, Manharashtra. It now has 4 hospitals in Maharashtra.
  • KIMS signs MoU with Wipro GE Healthcare

    18 Oct 2024 , 2:13PM KIMS signs MoU with Wipro GE Healthcare Valuing Up To Rs. 700 crore
  • Krishna Institute of Medical Science

    31 May 2024 , 12:05PM KIMS HOSPITALS announces expansion by setting up of 350 bed Super Specialty Hospital in Bengaluru, Karnataka at People Education Society (PES). PES is a university of repute and conducts several educational courses in various parts of the country. PES is in the process of setting up a medical college along with a teaching hospital at its campus at Electronics City, Bengaluru. PES is undertaking the construction and development of the building to house an approximately 350 bedded hospital, comprising of Ground Floor and 11 Upper Floors, totally measuring 3,50,000 square feet of built-up area, along with utility area and bunker for radiation oncology. KIMS Hospital Bengaluru Pvt. Ltd, a subsidiary of Krishna Institute of Medical Sciences Limited (KIMS) entered into a lease deed of 25 years and availed on lease the land and hospital building, for the purposes of setting up the Super Specialty Hospital from PES. (Positive)
  • Krishna Institute of Medical Sciences

    2 Aug 2023 , 2:05PM The company informed that it has made further investments in Sarvejana Healthcare Pvt Ltd. (Sunshine Hospital), a subsidiary of the company, by acquiring additional 2.49% stake in the company as a strategic investment. As a result, the company now owns 59.1% shareholding in Sarvejana. Sunshine Hospital generated sales of Rs. 288.3 Cr in FY23. The deal values Sunshine Hospital at 4.9x its FY23 sales. Positive read through. We do not have it in coverage.

Key fundamentals

Evaluate the intrinsic value of Krishna Institute of Medical Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 2876 2192.742 1635.029 1395.956 1027.669
Liabilities 2876 2192.742 1635.029 1395.956 1027.669
Equity 80 80.028 80.028 80.028 77.593
Gross Profit 416.5 364.407 360.283 396.22 304.029
Net Profit 302.9 235.341 252.489 278.367 188.649
Cash From Operating Activities 293.6 262.389 269.962 284.374 291.349
NPM(%) 21.88 19.25 22.3 24.34 20.22
Revenue 1384.1 1222.054 1132.023 1143.376 932.689
Expenses 967.6 857.647 771.74 747.156 628.66
ROE(%) 13.34 10.36 11.12 12.26 8.3

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Krishna Institute of Medical Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 750.20 0.91 44.55 398.85 301.39 0.67
Lotus Eye Hospital and Institute Ltd 113.08 -4.87 364.77 1453.35 3.55 0.00
Vaishali Pharma Ltd 7.95 0.13 0.00 9117.34 3.13 0.00
Astec Lifesciences Ltd 636.90 -1.78 0.00 1370.54 -604.77 0.00

Company Info

The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'. 2025 -The Company has informed that its wholly owned subsidiary, KIMS Hospital Bengaluru Private Limited, has commenced operations at its newly established hospital in Mahadevapura, Bengaluru.

The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'. 2025 -The Company has informed that its wholly owned subsidiary, KIMS Hospital Bengaluru Private Limited, has commenced operations at its newly established hospital in Mahadevapura, Bengaluru.

Read More

Parent Organisation

Krishna Institute of Medical Sciences Ltd.

Founded

26/07/1973

Managing Director

Dr.Abhinay Bollineni

NSE Symbol

KIMSEQ

FAQ

The current price of Krishna Institute of Medical Sciences Ltd is ₹ 687.20.

The 52-week high for Krishna Institute of Medical Sciences Ltd is ₹ 709.55 and the 52-week low is ₹ 670.15.

The market capitalization of Krishna Institute of Medical Sciences Ltd is currently ₹ 27497.55. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Krishna Institute of Medical Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Krishna Institute of Medical Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Krishna Institute of Medical Sciences Ltd shares.

The CEO of Krishna Institute of Medical Sciences Ltd is Dr.Abhinay Bollineni, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT